Cite
Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis.
MLA
Khosla, Harshit, et al. “Enfortumab-Vedotin Use for Urothelial Carcinoma in Two Patients on Hemodialysis.” Journal of Oncology Pharmacy Practice, vol. 30, no. 5, July 2024, pp. 941–44. EBSCOhost, https://doi.org/10.1177/10781552241237752.
APA
Khosla, H., Bhatt, S., Wang, M.-J., Gignac, G., Mittal, K., & Patel, J. (2024). Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis. Journal of Oncology Pharmacy Practice, 30(5), 941–944. https://doi.org/10.1177/10781552241237752
Chicago
Khosla, Harshit, Sita Bhatt, Ming-Jin Wang, Gretchen Gignac, Kriti Mittal, and Jasmine Patel. 2024. “Enfortumab-Vedotin Use for Urothelial Carcinoma in Two Patients on Hemodialysis.” Journal of Oncology Pharmacy Practice 30 (5): 941–44. doi:10.1177/10781552241237752.